Ideas to Action:

Independent research for global prosperity

X

Global Health Policy Blog

Feed

There is an interesting discussion at EconLog about the economics of vaccines. This follows a suggestion that some firms might not want to develop a vaccine for diseases such as malaria and AIDS because it is more profitable to sell drugs than prevent the disease with vaccines.

Arnold Kling reaches the same conclusion as the Working Group on Making Markets for Vaccines:

I had lunch with Tim Harford last week, and he pointed out that the problem with vaccines is that they are so valuable that governments cannot resist taking them. It is safer to develop something like Viagra, whose patent the government is unlikely to violate, than a cure for AIDS, because the latter is likely to be appropriated by government.

Related Topics:

Disclaimer

CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.